
InVitro International (IVRO)
IVRO Stock Price Chart
Explore InVitro International interactive price chart. Choose custom timeframes to analyze IVRO price movements and trends.
IVRO Company Profile
Discover essential business fundamentals and corporate details for InVitro International (IVRO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
16 May 1991
Employees
6.00
Website
https://www.invitrointl.comCEO
W. Richard Ulmer
Description
InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Placentia, California.
IVRO Financial Timeline
Browse a chronological timeline of InVitro International corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2023
EPS came in at $0.00 , while revenue for the quarter reached $211.63K .
IVRO Stock Performance
Access detailed IVRO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.